Position in LLY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$786,973,675
+$174,288,205 QoQ
Shares Held
656,123
-1.5% QoQ
Ownership
0.070%
of shares outstanding
% of Portfolio
6.29%
of 13F equity value
Holder Rank
#107
of 4,621 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BAHL & GAYNOR INC holds $1,357,498,569 across 6 Drug Manufacturers - General names. LLY ranks #1 (58.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
656,123 | $786,973,675 | |
| 2 | JNJ |
Johnson & Johnson
|
1,970,876 | $500,543,377 | |
| 3 | AMGN |
Amgen Inc
|
186,593 | $67,569,057 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
28,240 | $1,627,188 | |
| 5 | PFE |
Pfizer Inc
|
20,743 | $499,491 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,262 | $285,781 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $786,973,675 | 656,123 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $612,685,470 | 666,129 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $846,181,617 | 787,380 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $613,436,740 | 803,980 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $648,170,620 | 831,489 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $697,398,404 | 844,400 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $657,659,080 | 851,890 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $765,096,012 | 863,598 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $783,476,920 | 865,357 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $682,892,509 | 877,799 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $522,628,000 | 896,569 | Shares | Sole | 2024-02-02 | |
| 2023-09-30 | $502,255,760 | 935,073 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $451,696,679 | 963,147 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $380,598,992 | 1,108,261 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $357,987,244 | 978,535 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $338,599,185 | 1,047,160 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $318,945,374 | 983,701 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $248,573,455 | 868,015 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $328,078,094 | 1,187,742 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $280,763,641 | 1,215,164 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $273,328,711 | 1,190,871 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $216,063,120 | 1,156,531 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $194,414,870 | 1,151,474 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $162,719,126 | 1,099,305 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $182,108,127 | 1,109,198 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $149,531,836 | 1,077,940 | Shares | Sole | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||